Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.
A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta.
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Fatigue and sleep disturbance in multiple sclerosis.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Simvastatin Treatment of Patients With Acute Optic Neuritis
Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study.
Immunotherapy of Neuromyelitis Optica.
Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the International MS Falls Prevention Research Network.
What is new in MS spasticity research? Poster session highlights.
How Patients With Multiple Sclerosis Perceive Cognitive Slowing.
Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study.
S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
Cognitive functioning in pediatric transverse myelitis.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
Bilateral hypogeusia caused by a small lesion in the lower midbrain tegmentum.
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.

Pages